We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.53B
1-Year Est. Return 154.61%
This Fund
S&P 500
This Quarter Est. Return
-11.79%
1 Year Est. Return
+154.61%
3 Year Est. Return
+564.07%
5 Year Est. Return
+985.88%
10 Year Est. Return
–
AUM
$227M
AUM Growth
-$29.8M
Cap. Flow
+$4.07M
Cap. Flow %
1.79%
Top 10 Hldgs %
39.83%
Holding
81
New
31
Increased
12
Reduced
7
Closed
30

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$10.7M
2
AZN icon
AstraZeneca
AZN
+$8.94M
3
EHC icon
Encompass Health
EHC
+$8.33M
4
CTLT
CATALENT, INC.
CTLT
+$8.19M
5
DHR icon
Danaher
DHR
+$7.6M

Top Sells

Rank Stock Value
1
A icon
Agilent Technologies
A
+$14.5M
2
DXCM icon
DexCom
DXCM
+$13.1M
3
AMED
Amedisys
AMED
+$10.8M
4
SNY icon
Sanofi
SNY
+$9.54M
5
VAR
Varian Medical Systems, Inc.
VAR
+$8.52M

Sector Composition

Rank Sector Weight
1 Healthcare 93.4%
2 Energy 3.09%
3 Miscellaneous 1.86%
4 Consumer Discretionary 1.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
1
Medtronic
MDT
$113B
$10.4M 4.57%
115,000
+10,000
+10% +$1.06M
CNC icon
2
Centene
CNC
$30.5B
$10.1M 4.45%
170,000
+45,000
+36% +$2.73M
MRK icon
3
Merck
MRK
$367B
$10M 4.41%
+136,240
New +$10.7M
BMY icon
4
Bristol-Myers Squibb
BMY
$128B
$9.76M 4.3%
175,000
-15,000
-8% -$917K
DGX icon
5
Quest Diagnostics
DGX
$26.1B
$9.64M 4.24%
120,000
+40,000
+50% +$4.14M
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$11.7B
$9.29M 4.09%
110,000
– –
AZN icon
7
AstraZeneca
AZN
$258B
$8.48M 3.74%
+95,000
New +$8.94M
CTLT
8
DELISTED
CATALENT, INC.
CTLT
$7.79M 3.43%
+150,000
New +$8.19M
CCXI
9
DELISTED
ChemoCentryx, Inc.
CCXI
$7.63M 3.36%
190,000
+140,000
+280% +$5.94M
EHC icon
10
Encompass Health
EHC
$12.2B
$7.36M 3.24%
+144,555
New +$8.33M
LHCG
11
DELISTED
LHC Group LLC
LHCG
$7.01M 3.09%
+50,000
New +$6.96M
DHR icon
12
Danaher
DHR
$158B
$6.92M 3.05%
+56,400
New +$7.6M
GWPH
13
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$6.57M 2.89%
75,000
+55,000
+275% +$5.82M
MASI
14
DELISTED
Masimo
MASI
$6.2M 2.73%
+35,000
New +$6M
NVS icon
15
Novartis
NVS
$276B
$5.77M 2.54%
+70,000
New +$6.25M
BDX icon
16
Becton Dickinson
BDX
$50.1B
$5.74M 2.53%
+25,625
New +$6.33M
AGIO icon
17
Agios Pharmaceuticals
AGIO
$1.95B
$5.32M 2.34%
150,000
-40,000
-21% -$1.85M
SAGE
18
DELISTED
Sage Therapeutics
SAGE
$4.88M 2.15%
170,000
+50,000
+42% +$2.9M
EXAS
19
DELISTED
Exact Sciences
EXAS
$4.64M 2.04%
+80,000
New +$6.49M
ARNA
20
DELISTED
Arena Pharmaceuticals Inc
ARNA
$4.62M 2.04%
110,000
+40,000
+57% +$1.83M
BSX icon
21
Boston Scientific
BSX
$63.7B
$4.08M 1.8%
125,000
-75,000
-38% -$2.93M
NVRO
22
DELISTED
NEVRO CORP.
NVRO
$4M 1.76%
+40,000
New +$4.81M
XRAY icon
23
Dentsply Sirona
XRAY
$1.87B
$3.88M 1.71%
+100,000
New +$5.1M
CYTK icon
24
Cytokinetics
CYTK
$8.99B
$3.77M 1.66%
+320,000
New +$4.08M
CHWY icon
25
Chewy
CHWY
$7.34B
$3.75M 1.65%
+100,000
New +$2.94M
1
2 3 4

Similar funds

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.53B AUM 24.4% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.54B AUM 18.96% 1-Year Est. Return
QT
Quantbot Technologies New York $2.54B AUM 22.25% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.53B AUM 37.62% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.54B AUM 23.56% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.54B AUM 17.62% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.52B AUM 26.26% 1-Year Est. Return

Integral Health Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Integral Health Asset Management held 81 positions worth $227M, down 12% from $257M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Integral Health Asset Management's Q1 2020 filing shows 31 new, 12 increased, 7 reduced and 30 closed positions. Its largest new stake was Merck: 136,240 shares worth $10M. The largest sale was Agilent Technologies, an estimated $14.5M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 99% a quarter earlier, followed by Energy and Miscellaneous.

  • Integral Health Asset Management's largest Q1 2020 buy was Merck: 136,240 shares worth $10M.
  • Integral Health Asset Management added most to ChemoCentryx, Inc. in Q1 2020, an estimated $5.94M increase.
  • Integral Health Asset Management's biggest Q1 2020 reduction was Humana, cutting an estimated $6.07M.
  • Integral Health Asset Management fully exited Agilent Technologies in Q1 2020, selling an estimated $14.5M.
  • Integral Health Asset Management's ten largest holdings make up 40% of its $227M portfolio in Q1 2020.
  • Integral Health Asset Management opened 31 new positions and closed 30 in Q1 2020.
  • Integral Health Asset Management's portfolio value fell 12% quarter-over-quarter to $227M.

Based on Integral Health Asset Management's 13F filing for Q1 2020, filed 15 May 2020.